TY - JOUR
KW - urine drug screen
KW - buprenorphine-naloxone
KW - opioid use disorder
KW - Medications for treatment of opioid use disorder (MOUD)
KW - Empirical Study
KW - Longitudinal Study
KW - Retrospective Study
KW - Quantitative Study
KW - Human
KW - Male
KW - Female
KW - Adulthood (18 yrs & older)
KW - Drug Usage Screening
KW - Urine
KW - naloxone
KW - buprenorphine
KW - Drug Therapy
KW - Primary Health Care
KW - Substance use treatment
KW - article
KW - US
KW - 3383:Drug & Alcohol Rehabilitation
AU - Halle G. Sobel
AU - Jill S. Warrington
AU - Samuel Francis-Fath
AU - Abigail M. Crocker
AU - Claudia A. Berger
A1 - 
AD - University of Vermont, Robert Larner College of Medicine, Burlington, VT, US Halle.sobel@uvmhealth.org; Sobel, Halle G.,Halle.sobel@uvmhealth.org
BT - Addiction Science & Clinical Practice
C5 - Education & Workforce; Opioids & Substance Use
DO - 10.1186/s13722-021-00264-4
JF - Addiction Science & Clinical Practice
LA - English
M1 - Journal Article
PY - 2021
SN - 1940-0632, 1940-0632
SP - 5
T1 - A descriptive analysis of urine drug screen results in patients with opioid use disorder managed in a primary care setting
T2 - Addiction Science & Clinical Practice
TI - A descriptive analysis of urine drug screen results in patients with opioid use disorder managed in a primary care setting
U1 - Education & Workforce; Opioids & Substance Use
U3 - 10.1186/s13722-021-00264-4
VL - 16
VO - 1940-0632, 1940-0632
Y1 - 2021
Y2 - Sep 30
ER -